Bora Pharmaceuticals is an international contract development and manufacturing organization (CDMO) that specializes in complex oral solid dosage (OSD), semi-solids, and liquids. They provide a full spectrum of services, including drug development, clinical trial material manufacturing, commercial production, packaging, and analytical services. Bora is known for its technical expertise, high-quality standards (inspected by FDA, EMA, Health Canada, TFDA, etc.), and customer-centric approach, serving pharmaceutical companies worldwide from its facilities in Asia and North America. They aim to be a trusted partner for pharmaceutical companies looking to outsource their development and manufacturing needs.
The headquarters serves as the central command for Bora's global operations, housing corporate management, strategic planning, R&D oversight, and business development functions. It coordinates activities across its international manufacturing sites.
The Zhunan facility includes advanced R&D laboratories, modern manufacturing suites compliant with international cGMP standards, and administrative offices designed to foster collaboration and innovation.
The work culture at Bora's headquarters emphasizes precision, quality, continuous improvement, and a strong customer focus. Employees are encouraged to be innovative and collaborative in solving complex pharmaceutical challenges.
Its location in Taiwan provides access to a skilled workforce, a strong local pharmaceutical ecosystem, and a strategic position for serving both Asian and global markets. It's the nerve center for Bora's expanding global CDMO footprint.
Bora Pharmaceuticals operates a global network supporting pharmaceutical clients worldwide. Key functions supported globally include: contract development (formulation, analytical), clinical trial manufacturing, commercial-scale manufacturing (oral solids, liquids, semi-solids, sterile injectables), packaging services, and regulatory support. Their facilities in Taiwan, Canada, and Spain allow them to serve markets across Asia, North America, Europe, and other international regions, ensuring a resilient and responsive global supply chain.
No. 10, Keji 5th Rd., Zhunan Township
Zhunan
Miaoli County
Taiwan
Address: 6350 Viscount Road, Mississauga, ON L4V 1H3, Canada
To provide end-to-end pharmaceutical development and manufacturing solutions for North American clients and support global supply chains.
Address: No. 6, Luke 5th Rd., Xinshi Dist., Tainan City 74147, Taiwan
To expand Bora's manufacturing capabilities within Taiwan, complementing the Zhunan site and supporting global pharmaceutical supply with a focus on specialized technologies or capacities.
Address: C/ Sant Martí, s/n, Pol. Ind. La Torre, 08107 Martorelles, Barcelona, Spain
To establish a strong sterile manufacturing footprint in Europe, catering to the growing demand for injectable drug products and providing European market access for clients.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Bora Pharmaceuticals' leadership includes:
Bora Pharmaceuticals has been backed by several prominent investors over the years, including:
Bora Pharmaceuticals has maintained a relatively stable core executive team, focusing on integrating recent acquisitions and expanding global capabilities. Any significant changes would typically be announced via official press releases or regulatory filings.
Discover the tools Bora Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Bora Pharmaceuticals typically uses a standard corporate email format. The most common structure is likely [first].[last]@bora-corp.com or [first_initial][last]@bora-corp.com. Variations might exist for different departments or regions.
[first].[last]@bora-corp.com
Format
jane.doe@bora-corp.com
Example
80%
Success rate
Bora Pharmaceuticals Press Release • February 29, 2024
Bora Pharmaceuticals was honored as the Best Contract Development and Manufacturing Organization (CDMO) at the 2024 Global Generics & Biosimilars Awards. This award recognizes Bora's excellence in service, quality, and innovation within the pharmaceutical contract manufacturing sector....more
Bora Pharmaceuticals Press Release • October 26, 2023
Bora Pharmaceuticals announced the successful completion of its acquisition of a sterile manufacturing facility from Laboratorios Farmacéuticos Rovi, S.A. (formerly owned by Esteve) located in Martorelles, Spain. This strategic acquisition expands Bora's capabilities into sterile drug product manufacturing and strengthens its presence in the European market....more
Bora Pharmaceuticals Newsroom • May 10, 2023
Bora Pharmaceuticals' Mississauga facility in Canada successfully completed a U.S. Food and Drug Administration (FDA) Pre-Approval Inspection (PAI) with no Form 483 observations issued, underscoring its commitment to high-quality manufacturing standards....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Bora Pharmaceuticals, are just a search away.